Holen Sie sich die Stockscreener-App
1.60
8.84%
0.13
Handel nachbörslich:
1.60
Schlusskurs vom Vortag:
$1.47
Offen:
$1.46
24-Stunden-Volumen:
320.50K
Relative Volume:
2.79
Marktkapitalisierung:
$119.23M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-19.57M
KGV:
-0.5112
EPS:
-3.13
Netto-Cashflow:
$-17.24M
1W Leistung:
+2.56%
1M Leistung:
-3.61%
6M Leistung:
-28.89%
1J Leistung:
-39.39%
1-Tages-Spanne:
$1.33
$1.76
1-Wochen-Bereich:
$1.33
$1.76
52-Wochen-Spanne:
$1.33
$4.20
Inhibikase Therapeutics Inc Stock (IKT) Company Profile
Firmenname
Inhibikase Therapeutics Inc
Sektor
Branche
Telefon
(302) 295-3800
Adresse
1000 N. WEST STREET, SUITE 1200, WILMINGTON
Vergleichen Sie IKT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IKT
Inhibikase Therapeutics Inc
|
1.60 | 109.54M | 0 | -19.57M | -17.24M | -3.13 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Inhibikase Therapeutics Inc Stock (IKT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-12 | Herabstufung | H.C. Wainwright | Buy → Neutral |
Inhibikase Therapeutics Inc Aktie (IKT) Neueste Nachrichten
Will Inhibikase Therapeutics Inc. stock beat EPS estimatesJuly 2025 Momentum & Free Expert Approved Momentum Trade Ideas - newser.com
What makes Inhibikase Therapeutics Inc. stock attractive to growth funds2025 Market Outlook & Risk Managed Investment Signals - newser.com
Why Inhibikase Therapeutics Inc. (IQT0) stock trades below fair value2025 Trading Volume Trends & Free Safe Entry Trade Signal Reports - newser.com
What institutional flow reveals about Inhibikase Therapeutics Inc.Weekly Gains Report & Smart Money Movement Tracker - newser.com
Will Inhibikase Therapeutics Inc. price bounce be sustainable2025 Stock Rankings & Expert Curated Trade Ideas - newser.com
Key resistance and support levels for Inhibikase Therapeutics Inc.2025 Price Momentum & Growth Oriented Trade Recommendations - newser.com
Will Inhibikase Therapeutics Inc. (IQT0) stock top growth indexesTrend Reversal & High Conviction Trade Alerts - newser.com
Is Inhibikase Therapeutics Inc. (IQT0) stock overpriced at current multiplesWeekly Stock Summary & Smart Swing Trading Techniques - newser.com
Will Inhibikase Therapeutics Inc. stock recover after recent dropWeekly Trade Review & Long-Term Capital Growth Ideas - newser.com
Signal strength of Inhibikase Therapeutics Inc. stock in tech scannersTrade Entry Summary & Weekly Watchlist of Top Performers - newser.com
Can Inhibikase Therapeutics Inc. stock reach $100 price target2025 Bull vs Bear & Verified Entry Point Signals - newser.com
Can volume confirm reversal in Inhibikase Therapeutics Inc.Gold Moves & AI Forecast Swing Trade Picks - newser.com
Top chart patterns to watch in Inhibikase Therapeutics Inc.Portfolio Gains Report & Daily Technical Stock Forecast Reports - newser.com
Can Inhibikase Therapeutics Inc. recover in the next quarter2025 Technical Overview & Accurate Entry and Exit Point Alerts - newser.com
Why Inhibikase Therapeutics Inc. (IQT0) stock is a strong analyst pickJuly 2025 Opening Moves & Reliable Price Action Trade Plans - newser.com
Why Inhibikase Therapeutics Inc. stock is a must watch in 2025Earnings Growth Report & Reliable Volume Spike Trade Alerts - newser.com
Analyzing Inhibikase Therapeutics Inc. with risk reward ratio chartsWeekly Trend Recap & Long-Term Safe Investment Plans - newser.com
How to build a dashboard for Inhibikase Therapeutics Inc. stockWeekly Market Summary & Real-Time Volume Triggers - newser.com
Will Inhibikase Therapeutics Inc. stock attract ESG investorsJuly 2025 Retail & Advanced Technical Signal Analysis - newser.com
Can Inhibikase Therapeutics Inc. stock maintain operating marginsPortfolio Value Report & Stepwise Trade Execution Plans - newser.com
Will Inhibikase Therapeutics Inc. (IQT0) stock profit from AI boomJuly 2025 Final Week & Risk Adjusted Buy and Sell Alerts - newser.com
Is Inhibikase Therapeutics Inc. (IQT0) stock a defensive play amid uncertaintyJuly 2025 Price Swings & Capital Efficiency Focused Strategies - newser.com
How Inhibikase Therapeutics Inc. stock compares to growth peers2025 Dividend Review & Community Driven Trade Alerts - newser.com
Earnings visualization tools for Inhibikase Therapeutics Inc.Portfolio Return Summary & Verified Momentum Stock Ideas - newser.com
Why Inhibikase Therapeutics Inc. (IQT0) stock fits value portfolios2025 Price Momentum & Short-Term Swing Trade Alerts - newser.com
Is Inhibikase Therapeutics Inc. reversing from oversold territoryInsider Buying & Real-Time Market Trend Scan - newser.com
Why Inhibikase Therapeutics Inc. stock appeals to analysts2025 Top Decliners & Daily Profit Focused Screening - newser.com
Tools to monitor Inhibikase Therapeutics Inc. recovery probabilityJuly 2025 Action & Weekly High Potential Alerts - newser.com
Finanzdaten der Inhibikase Therapeutics Inc-Aktie (IKT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):